Claus Hellerbrand

Claus Hellerbrand's AcademicInfluence.com Rankings

Claus Hellerbrand

Biology

#12560

World Rank

#16043

Historical Rank

Cell Biology

#672

World Rank

#686

Historical Rank

Molecular Biology

#2052

World Rank

#2084

Historical Rank

Biochemistry

#2150

World Rank

#2295

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Claus Hellerbrand Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Claus Hellerbrand's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME (2013) (1068)
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. (1998) (456)
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis (2015) (376)
The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. (1999) (339)
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. (2014) (325)
Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes (2009) (317)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis (2018) (316)
PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis (2006) (304)
Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis (2010) (301)
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians (2010) (291)
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. (2009) (288)
Intestinal fungi contribute to development of alcoholic liver disease (2017) (273)
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans (2005) (262)
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma (2009) (258)
Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. (1998) (255)
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. (2011) (224)
Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells (1997) (215)
PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. (2006) (211)
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis (2004) (207)
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. (2003) (206)
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma (2009) (206)
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells (2009) (204)
Animal models of chronic liver diseases. (2013) (188)
Deficiency of intestinal mucin‐2 ameliorates experimental alcoholic liver disease in mice (2013) (184)
The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis (2008) (179)
Inhibition of NFκB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super‐repressor (1998) (171)
Reduced expression of CYLD in human colon and hepatocellular carcinomas. (2007) (167)
Association between serum ferritin and the insulin resistance syndrome in a representative population. (2006) (167)
GLUT1 as a therapeutic target in hepatocellular carcinoma (2009) (167)
Expression of fatty acid synthase in nonalcoholic fatty liver disease. (2010) (167)
Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications (2010) (167)
Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells (1996) (161)
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. (2016) (161)
DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma (2011) (147)
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. (2009) (147)
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas (2009) (134)
Hypoxia‐inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia‐inducible factor‐1 (2010) (133)
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. (2008) (127)
Targeting FGFR/PDGFR/VEGFR Impairs Tumor Growth, Angiogenesis, and Metastasis by Effects on Tumor Cells, Endothelial Cells, and Pericytes in Pancreatic Cancer (2011) (126)
Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors (1998) (125)
Hepatic stellate cells—the pericytes in the liver (2013) (120)
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. (2013) (115)
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. (2010) (113)
Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. (2011) (110)
Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol‐associated cancer in heavy drinkers (2006) (109)
Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis (2012) (102)
Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC (2011) (101)
TNFalpha is required for cholestasis-induced liver fibrosis in the mouse. (2009) (100)
Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. (2010) (96)
BMP-9 interferes with liver regeneration and promotes liver fibrosis (2017) (94)
Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. (2010) (94)
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis (2018) (93)
[S2k Guideline non-alcoholic fatty liver disease]. (2015) (92)
Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. (1998) (92)
Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. (2006) (91)
Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen. (2015) (90)
Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression (2009) (89)
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. (2005) (89)
Regulatory Role of the Conserved Stem-Loop Structure at the 5′ End of Collagen α1(I) mRNA (1999) (89)
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME (2013) (84)
Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. (1998) (83)
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. (2009) (82)
HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. (2003) (81)
Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell‐cycle control and apoptosis (2014) (79)
Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells (2015) (79)
Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis (2017) (78)
Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells. (2004) (78)
Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. (2006) (77)
Transforming growth factor-β1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection (2005) (77)
Increased expression of c-Jun in nonalcoholic fatty liver disease (2013) (76)
Loss of E-cadherin leads to upregulation of NFκB activity in malignant melanoma (2004) (76)
Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease. (2004) (74)
Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells. (2009) (73)
Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition (2010) (73)
A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. (2011) (72)
Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice (2014) (72)
Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. (2004) (71)
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. (2008) (68)
Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. (2008) (68)
Wild type Kirsten rat sarcoma is a novel microRNA-622-regulated therapeutic target for hepatocellular carcinoma and contributes to sorafenib resistance (2017) (68)
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma (2007) (67)
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo (2008) (67)
Frequent expression of the novel cancer testis antigen MAGE‐C2/CT‐10 in hepatocellular carcinoma (2009) (65)
Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different (2014) (64)
Hepatitis C – contamination of toothbrushes: myth or reality? (2006) (63)
Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells (2007) (61)
Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. (2010) (61)
Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. (2010) (60)
Targeting heat‐shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice (2009) (60)
Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver (2012) (60)
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro (2019) (58)
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. (2014) (58)
miR‐30c and miR‐193 are a part of the TGF‐β‐dependent regulatory network controlling extracellular matrix genes in liver fibrosis (2015) (57)
Expression of Serotonin Receptors in Human Hepatocellular Cancer (2012) (56)
Comparison of interobserver agreement for different scoring systems for reflux esophagitis: Impact of level of experience. (2004) (55)
Xanthohumol feeding does not impair organ function and homoeostasis in mice. (2010) (55)
Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. (2010) (55)
Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). (2011) (54)
Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis (2011) (53)
Deregulation of protein methylation in melanoma. (2013) (52)
Formation of Fenestrae in Murine Liver Sinusoids Depends on Plasmalemma Vesicle-Associated Protein and Is Required for Lipoprotein Passage (2014) (51)
The potential of silymarin for the treatment of hepatic disorders (2016) (51)
Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. (2010) (49)
Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies. (2010) (47)
Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease (2016) (47)
Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. (2006) (47)
Repression of Cytochrome P450 Activity in Human Hepatocytes in Vitro by a Novel Hepatotrophic Factor, Augmenter of Liver Regeneration (2006) (47)
Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. (2012) (46)
The Marburg I variant (G534E) of the factor VII–activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet‐derived growth factor BB (2009) (46)
FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice. (2010) (45)
TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. (2005) (45)
Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. (2005) (45)
Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma (2007) (44)
Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome. (2010) (42)
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels (2015) (41)
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease (2014) (41)
Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. (2011) (41)
Specific Expression and Regulation of the New Melanoma Inhibitory Activity-related Gene MIA2 in Hepatocytes* (2003) (40)
Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury. (2007) (40)
Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. (2005) (40)
Insulin‐like growth factor II mRNA‐binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value (2012) (39)
Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function. (2011) (39)
A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. (2008) (38)
Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats (2015) (37)
Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. (2015) (37)
Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models (2017) (37)
Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition (2018) (37)
Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD). (2015) (37)
High predictive value ofToxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis (1996) (36)
Hepatocellular Carcinoma in Southern Germany: Epidemiological and Clinicopathological Characteristics and Risk Factors (2002) (36)
Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction (2011) (36)
Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis. (2010) (35)
Prevents Apoptosis and Liver Dysfunction during Liver Regeneration (1998) (35)
Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection. (2003) (34)
Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. (2014) (34)
Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels (2016) (34)
Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease (2003) (34)
Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. (2013) (34)
Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal (2009) (34)
Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. (2005) (33)
Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury. (2013) (33)
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis (2017) (32)
Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes (2011) (32)
Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice (2016) (32)
Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis. (2005) (32)
Uncoupling of sympathetic nervous system and hypothalamic‐pituitary‐adrenal axis in cirrhosis (2008) (32)
mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma (2015) (32)
Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma1 (2019) (32)
Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7 (2014) (31)
MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis. (2011) (31)
Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy (2011) (31)
Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells. (1998) (30)
Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. (2010) (30)
Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany. (2010) (30)
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma (2019) (29)
Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma (2005) (29)
Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation. (2011) (29)
Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. (2008) (29)
Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis. (2009) (29)
Up‐regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course (2007) (28)
Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity. (2013) (27)
Changes in the hepatic mitochondrial and membrane proteome in mice fed a non-alcoholic steatohepatitis inducing diet. (2013) (27)
Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma (2011) (27)
Hop bitter acids exhibit anti-fibrogenic effects on hepatic stellate cells in vitro. (2012) (26)
Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. (2005) (26)
Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition (2012) (25)
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option (2017) (25)
LPS-mediated NFκB activation varies between activated human hepatic stellate cells from different donors (2004) (25)
Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma (2015) (25)
Obesity and Fatty Liver Are ‘Grease’ for the Machinery of Hepatic Fibrosis (2011) (25)
Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration. (2011) (24)
BMP6-induced modulation of the tumor micro-milieu (2018) (24)
Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis. (2011) (24)
Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis (2009) (23)
Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro (2015) (23)
Xanthohumol uptake and intracellular kinetics in hepatocytes, hepatic stellate cells, and intestinal cells. (2011) (23)
Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin (2005) (23)
Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT. (2011) (23)
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma. (2018) (22)
Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas. (2014) (21)
Cylindromatosis—A Protective Molecule against Liver Diseases (2016) (21)
Rapid genetic screening for hemochromatosis using automated SSCP-based capillary electrophoresis (SSCP-CE). (1999) (21)
Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro. (2018) (21)
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers (2005) (21)
Early changes in the liver‐soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet (2012) (21)
Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10. (2005) (20)
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y. (2013) (20)
FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29. (2010) (19)
Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis (2019) (19)
MicroRNA‐622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma (2018) (19)
Expression of E-selectin ligand-1 (CFR/ESL-1) on hepatic stellate cells: implications for leukocyte extravasation and liver metastasis. (2009) (19)
Olive Oil Attenuates the Cholesterol-induced Development of Nonalcoholic Steatohepatitis Despite Increased Insulin Resistance in a Rodent Model (2013) (19)
Role of fibroblast growth factor signalling in hepatic fibrosis (2021) (18)
Hop bitter acids inhibit tumorigenicity of hepatocellular carcinoma cells in vitro. (2012) (17)
Dietary glycine blunts liver injury after bile duct ligation in rats. (2008) (17)
Characterization of glycolysis-related gene expression in malignant melanoma. (2019) (17)
Molecular cross-talk between Y5-receptor and neuropeptide Y drives liver cancer (2020) (17)
Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis12 (2018) (17)
Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation (2018) (17)
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro. (2011) (16)
Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model. (2015) (16)
LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors. (2003) (15)
Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis (2016) (15)
Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis. (2007) (15)
Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma (2011) (15)
Effect of acute beer ingestion on the liver: studies in female mice (2015) (15)
Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis. (2013) (15)
Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro (2019) (14)
Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models. (2010) (14)
Use of capillary electrophoresis for high throughput screening in biomedical applications. A minireview. (2000) (14)
Role of melanoma inhibitory activity in melanocyte senescence (2019) (14)
Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique. (2001) (14)
Pathophysiological Similarities and Synergisms in Alcoholic and Non-Alcoholic Steatohepatitis (2011) (14)
Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease. (2008) (14)
Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension. (2010) (13)
Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease. (2011) (13)
Post-transcriptional regulation of collagen alpha 1(I) mRNA in hepatic stellate cells. (1995) (13)
No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease. (2008) (13)
Alpha‐fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas (2009) (13)
An iso-α-acid-rich extract from hops (Humulus lupulus) attenuates acute alcohol-induced liver steatosis in mice. (2018) (13)
Expression and function of the atypical cadherin FAT1 in chronic liver disease. (2012) (13)
Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells (2021) (12)
Characterization of rat and human Kupffer cells after cryopreservation. (2007) (12)
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma (2020) (12)
BMP-9 Modulates the Hepatic Responses to LPS (2020) (12)
A TWO-STAGE GENOME-WIDE ASSOCIATION STUDY CONFIRMS PNPLA 3 AND IDENTIFIES TM 6 SF 2 AND MBOAT 7 AS RISK LOCI FOR ALCOHOL-RELATED CIRRHOSIS (2017) (12)
Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma (2020) (11)
Bone Morphogenetic Protein-6 Inhibits Fibrogenesis in Scleroderma Offering Treatment Options for Fibrotic Skin Disease. (2019) (11)
Genomewide genetic association studies in hepatology: The end of searching for the needle in the haystack? (2007) (10)
Herbs to treat liver diseases: More than placebo? (2015) (9)
Chronic Psychosocial Stress in Mice Is Associated With Increased Acid Sphingomyelinase Activity in Liver and Serum and With Hepatic C16:0-Ceramide Accumulation (2018) (9)
Analysis of carbohydrate deficient transferrin serum levels during abstinence. (2012) (9)
Molecular targets for antifibrotic therapy in liver disease: using magic bullets for crossfire rather than a one-sided shotgun attack (2013) (9)
Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye. (2021) (8)
Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview (2020) (8)
Effect of melanoma cells on proliferation and migration of activated hepatic stellate cells in vitro. (2017) (8)
LightCycler-analysis of the Transforming Growth Factor-beta1 Codon 25 Gene Polymorphism in German Patients with Chronic Hepatitis C Infection (2004) (8)
Iron-induced expression of BMP6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo (2010) (8)
Expression and Function of Methylthioadenosine Phosphorylase in Chronic Liver Disease (2013) (7)
The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression (2019) (7)
Enhanced expression of BMP 6 inhibits hepatic fi brosis in non-alcoholic fatty liver disease (2015) (6)
Inhibition of proinllammatory molecule expression by adenovirus-mediated expression of an NFkB super repressor in activated hepatic stellate cells (1998) (6)
Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun’s Nuclear Translocation and Activity (2019) (5)
Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11 (2021) (5)
Inhibition of NF (cid:107) B in Activated Rat Hepatic Stellate Cells by Proteasome Inhibitors and an I (cid:107) B Super-Repressor (1998) (5)
Secreted cysteine-rich FGF receptor derives from posttranslational processing by furin-like prohormone convertases. (2009) (5)
Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro (2019) (5)
Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. (2004) (5)
Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. (2015) (4)
β-Arrestin2 is increased in liver fibrosis in humans and rodents (2020) (4)
Identification of cytochrome CYP2E1 as critical mediator of alcohol effects on steatotic hepatocytes (2015) (4)
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury (2020) (4)
320 Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease (2004) (4)
Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism. (2018) (3)
Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma. (2005) (3)
with progression of liver fibrosis in Caucasians with chronic hepatitis C infection (2005) (3)
Characterization of the human zinc finger protein 267 promoter: essential role of nuclear factor Y. (2005) (3)
Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma (2005) (3)
316 FAT1 EXPRESSION IS INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTES TUMORIGENESIS (2012) (3)
OP0284 Long Noncoding RNA MIR503HG is a Novel Factor in the Pathogenesis of Systemic Sclerosis (2015) (3)
Promotor-Hypermethylation Is Causing Functional Relevant Downregulation of Methylthioadenosine Phosphorylase (MTAP) Expression in Hepatocellular Carcinoma (2005) (3)
Inhibition of monoacylglycerol lipase for the treatment of liver disease: tempting but still playing with fire (2018) (3)
Oral intake of xanthohumol attenuates lipoteichoic acid-induced inflammatory response in human PBMCs (2022) (3)
Re-evaluation of the genetic cirrhosis risk score in patients with chronic hepatitis C virus infection (2009) (3)
Interstrain differences in susceptibility to non-alcoholic steatohepatitis (2011) (3)
Down-regulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma (2011) (2)
Enhanced TLR4 expression in steatotic hepatocytes (2012) (2)
Expression of different histone deacetylases and functional effects of histone deacetylase inhibitors in hepatocellular carcinoma (2018) (2)
151 Protective Effect of Pd-L1/Pd-1 in Acute Hepatic Ischemia-Reperfusion Injury (2008) (2)
HFE gene mutations in patients with hepatocellular carcinoma (2000) (2)
Increased expression of pregnancy-associated plasma protein-A (PAPP-A) in hepatic stellate cells correlates with hepatic fibrosis and can be detected in the serum of patients with liver disease (2016) (2)
Effect of increased glucose transporter 1 (GLUT1) expression in activated hepatic stellate cells (2013) (2)
Colocalization analysis of pancreas eQTLs with risk loci from alcoholic and novel non-alcoholic chronic pancreatitis GWAS suggests potential disease causing mechanisms. (2022) (2)
Expression profile of fibroblast growth factors in hepatic stellate cells and experimental models of liver fibrosis (2018) (2)
Dual Inhibition of mTORC1/2 Reduces Migration of Cholangiocarcinoma Cells by Regulation of Matrixmetalloproteinases (2022) (2)
Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma (2021) (2)
Tumorsuppressive MicroRNA-188-5p Reveals Novel Oncogenes for Hepatocellular Carcinoma (2016) (2)
Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche (2022) (1)
Uptake of xanthohumol in human liver and intestinal cells (2009) (1)
UVB radiation represses CYLD expression in melanocytes (2017) (1)
Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-(methylthio)adenosine on tumor progression of hepatocellular carcinoma (2010) (1)
Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1 (2021) (1)
PD1/PD-L1 protects from inflammation and fibrosis in non-alcoholic steatohepatitis (2009) (1)
Posters02a. Cirrhosis and its Complications: Pathophysiology601 miR-133a MEDIATES TGF-b-DEPENDENT DE-REPRESSION OF COLLAGEN-SYNTHESIS IN HEPATIC STELLATE CELLS DURING LIVER FIBROSIS (2013) (1)
139 Complement factor 5 (C5) is a genetic determinant of liver fibrogenesis in mice and humans (2003) (1)
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer (2021) (1)
Elevated serum IGE is a specific marker for alcohol-related liver cirrhosis (2000) (1)
PD1 expression inhibits hepoatic inflammation and fibrosis in non-alcoholic steatohepatitis (2011) (1)
Combination of psychosocial stress and a NASH-inducing diet in mice (2013) (1)
Hop bitter acids inhibit tumorigenicity of hepatocellular carcinoma cells (2011) (1)
Increased expression of histone deacetylase 7 during hepatic stellate cell activation promotes pro-fibrogenic gene expression (2015) (1)
Corrigendum to “Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver” [Molecular and Cellular Endocrinology 349 (2012) 248–254] (2012) (1)
Hop bitter acids exhibit anti-fibrogenic effects an hepatic stellate cells in vitro (2011) (1)
[104] FUNCTIONAL AND GENETIC INTERACTION OF THE CHEMOKINES CCL (RANTES) AND CXCL (PF) IN CHRONIC LIVER DISEASES IN MICE AND HUMANS (2007) (1)
A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women (2022) (1)
[772] LIPID ACCUMULATION IN HEPATOCYTES INDUCES ACTIVATION AND PRO-FIBROTIC GENE EXPRESSION IN HEPATIC STELLATE CELLS - A NEW IN VITRO MODEL TO STUDY FIBROGENESIS IN NASH (2007) (1)
Analysis of Molecular Mechanisms of 5-Fluorouracil Induced Steatosis and Inflammation in Vitro and in Mice (2016) (1)
The potent modulator of cholesterol biosynthesis insulin-induced gene 1 (INSIG1) is a novel hypoxia-regulated tumor suppressor in hepatocellular carcinoma (2019) (1)
A novel in vitro model of alcohol-induced hepatic fibrogenesis (2011) (1)
MMP–9 activity is increased by adiponectin in primary human hepatocytes but negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis (2012) (1)
Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decrease during alcohol withdrawal (2008) (1)
Circulating Serum Markers Correlate with Liver Fibrosis in Patients with Chronic Hepatitis C (2005) (1)
Glucose transporter isoform 1 (GLUT1) expression enhances formation and growth of hepatic metastases (2013) (1)
Identification of the chemokine CXCL9 (MIG) as a genetic modifier of liver fibrosis in patients with hepatitis C (2006) (1)
GLUT1 and GLUT3 expression are increased in hepatocellular carcinoma and promote tumorigenesis (2009) (1)
A TWO-STAGE GENOME-WIDE ASSOCIATION STUDY IDENTIFIES TM6SF2 AND MBOAT7 AS RISK LOCI FOR ALCOHOL-RELATED CIRRHOSIS (2015) (1)
GENETIC PREDISPOSITION FOR ALCOHOL-ASSOCIATED GASTROIN-TESTINAL CANCER IN HEAVY DRINKERS WITH THE ALCOHOL DEHYDROGENASE 1C*1 ALLELE. (2004) (1)
163 XANTHOHUMOL SUPPRESSES HEPATIC INFLAMMATORY RESPONSE TO ACUTE LIVER INJURY (2012) (1)
A new model of synergistic effects of alcohol and high-fat diet on hepatic injury (2010) (1)
Analysis of molecular mechanisms of 5-fluorouracil-induced hepatic steatosis and inflammation in vitro and in mice (2016) (1)
Abstract 4373: Targeting FGFR system in a model of HCC (2012) (1)
Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumor progression (2009) (1)
Hop bitter acids inhibit PD-L1 expression and tumorigenicity of hepatocellular carcinoma cells (2012) (1)
Elevated systemic monocyte chemoattractrant protein-1 levels in hepatic steatosis without significant hepatic inflammation (2011) (1)
6655 The emerging role of the novel serum marker GOLPH2 in detecting and monitoring of hepatocellular carcinoma (2009) (1)
Heterozygous p53 knockout affects development of obesity, insulin resistance and non-alcoholic steatohepatitis in mice fed with a Western type diet (2013) (1)
Influence of DSS induced colitis in a model of experimental NASH (2009) (0)
Hepatic steatosis enhances growth and invasiveness of hepatocellular carcinoma (2014) (0)
Chronic and excessive alcohol consumption is causing elevated adiponectin serum levels (2006) (0)
ALR expression indicates liver regeneration upon distinct tissue damage (2010) (0)
The role of PI3K p110gamma in chronic liver injury (2012) (0)
ERK and p38 activation are central mediators of irinotecan-induced steatohepatitis (2015) (0)
1252 Homozygosity for the alcoholdehydrogenase 3*1 allele is associated with hepatocellular carcinoma in alcohol-induced cirrhosis (2003) (0)
Increased expression of the Glucose-transporter GLUT1 during hepatic stellate cell activation promotes hepatic fibrosis (2015) (0)
Bone morphogenetic protein 13 is expressed by activated hepatic stellate cells and promotes tumorigenicity of hepatocellular carcinoma (2022) (0)
The role of the pancreatic polypeptide-neuropeptide Y receptor 4-axis in hepatocellular carcinoma progression (2023) (0)
Ferritin-Mediated Iron Seq uestration Stabilizes Hypoxia-Inducible Factor-1 a upon LPS Activation in the Presence of Ample Oxygen Graphical (2015) (0)
706 INFLUENCE OF DSS INDUCED COLITIS IN A MODEL OF EXPERIMENTAL NASH (2009) (0)
Xanthohumol inhibits hepatitis B virus replication in vitro (2012) (0)
Representation of human non-alcoholic fatty liver disease in murine models (2015) (0)
Crucial role of beta-arrestin-2 in linking fibrogenesis and cancer (2020) (0)
SY24-3PATHOPHYSIOLOGICAL SIMILARITIES AND SYNERGISMS IN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE (2015) (0)
Expression of growth differentiation factor 5 in liver disease and cancer (2022) (0)
135 PD1/PD-L1 PROTECT FROM INFLAMMATION AND FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS (2009) (0)
M1567 CpG Motifs Induce Proinflammatory Events in Hepatic Stellate Cells and Are Involved in Bile Duct Ligation-Induced Hepatic Fibrosis In Vivo (2008) (0)
Expression of paracrine fibroblast growth factors in hepatic stellate cells and hepatic fibrosis (2021) (0)
Intercellular crosstalk regulating ARRB2/RARRES1 is involved in transition from fibrosis to cancer (2021) (0)
GLUT 1 expression favors formation and growth of hepatic metastasis (2012) (0)
999 HUMAN MONOCYTE SUBSETS ACCUMULATE INTRAHEPATICALLY IN LIVER CIRRHOSIS AND DIFFERENTIALLY INTERACT WITH HEPATIC STELLATE CELLS (2010) (0)
Expression and function of histone deacetylase 7 in hepatocellular carcinoma (2021) (0)
904 INCREASED EXPRESSION OF FAT1 IN HEPATOCELLULAR CARCINOMA PROMOTES TUMORIGENICITY (2010) (0)
1231 INTERSTRAIN DIFFERENCES IN SUSCEPTIBILITY TO NON-ALCOHOLIC STEATOHEPATITIS (2012) (0)
S01-4Alcohol and Obesity: A Dangerous Association for Fatty Liver Disease (2017) (0)
Systemic spreading of intraperitoneal Staphylococcus aureus is increased in experimental liver cirrhosis but unaltered by splanchnic sympathectomy (2010) (0)
Hepatic steatosis potentiates irinotecan-induced hepatocellular injury (2018) (0)
Histone deacetylases (HDAC) expressions in HCC and functional effects of HDAC inhibitors in liver cancer cells (2020) (0)
CYLD-Mediated Upregulation of Hepatocyte Growth Factor Prevents Hepatic Injury and Fibrosis (2013) (0)
504 GLUT1 AND GLUT3 EXPRESSION ARE INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTE TUMORIGENICITY (2009) (0)
Copy number variation of the CCL3L1 gene in chronic HCV infection: Influence on susceptibility and fibro-inflammatory response (2007) (0)
Cytochrome Cyp2e1 is critical for joint effects of alcohol and lipids on hepatocellular steatosis and inflammation (2013) (0)
P0298 : Glucose transporter isoform 1 (GLUT1) expression determines hepatic metastasis of melanoma cells (2015) (0)
IDENTIFICATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2111B (FGFRZIIIB) AS TUMOR SUPPRESSOR IN H EPATOCANCE ROGEN ESlS (2005) (0)
Anti-fibrogenic effects of sylimarin vary significantly in human hepatic stellate cells from different donors (2014) (0)
Role of Fibroblast Growth Factor 9 in bile acid homeostasis (2022) (0)
The MIA-2 protein (2003) (0)
Lipid-loaded hepatocytes release soluble factors that activate hepatic stellate cells: a new in vitro model to study fibrogenesis in NASH (2008) (0)
Adiponectin downregulates connective tissue growth factor in hepatocytes and hepatic stellate cells (2010) (0)
The novel gene MIA2 promotes progression of hepatocellular carcinoma (2006) (0)
Subject Index Vol. 28, 2010 (2011) (0)
Increased expression of the glucose transporter GLUT1 in liver fibrosis (2012) (0)
Mass spectrometry based metabolomics to study the development of Non-alcoholic steatohepatitis (2011) (0)
Variation of the expression of different Histone deacetylases (HDACs) and the functional effects of HDAC-inhibitors in hepatocellular carcinoma (2019) (0)
Deficiency of phosphatidylinositol 3-kinase (PI3K) aggravates inflammation and fibrosis in experimental non alcoholic steatohepatitis but protects against bile duct ligation induced liver fibrosis in vivo (2010) (0)
BMP6 protects against hepatic inflammation and fibrosis in experimental NASH models (2012) (0)
1249 IN VITRO AND IN VIVO MODELS FOR CHEMOTHERAPY-ASSOCIATED STEATOHEPATITIS REVEAL AN EFFECT OF IRINOTECAN ON FATTY ACID BINDING PROTEIN EXPRESSION (2012) (0)
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis (2022) (0)
Contents Vol. 28, 2010 (2011) (0)
Iso-Alpha Acids (IAA) from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation and fibrosis (2016) (0)
P1125 : Alcohol induces pathological as well as protective mechanisms in steatotic hepatocytes (2015) (0)
[69] IDENTIFICATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2IIIB (FGFR2IIIB) AS TUMOR SUPPRESSOR IN HEPATOCANCEROGENESIS (2007) (0)
[453] ASSOCIATION OF CCBP2, A SCAVENGER RECEPTOR FOR INFLAMMATORY CC CHEMOKINES, WITH LIVER INFLAMMATION IN MICE AND HUMANS (2007) (0)
THU-465-Variation of different histone deacetylases and the functional effects of HDAC inhibitors in hepatocellular carcinoma (2019) (0)
Expression and function of methylthioadenosine phosphorylase (MTAP) in activated hepatic stellate (2014) (0)
Association between serum ferritin and the insulin resistance syndrome (IRS) in a representative German population (2004) (0)
Autophagy impairment and ERK and p38 activation are central mediators of irinotecan-induced steatohepatitis (2015) (0)
Sorafenib-resistance is mediated by a novel Kirsten rat sarcoma-microRNA-axis in hepatocellular carcinoma (2018) (0)
Different Effects of the Functional MCP–1 Polymorphism (A–2518G) on Hepatic Fibrosis and Hepatocancerogenesis (2005) (0)
Xanthohumol suppresses hepatic inflammatory response to warm ischemia-reperfusion injury (2012) (0)
The long non-coding RNAs lnc-ADM-2 and lnc-NBPF3-9 represent potential novel targets in hepatocellular carcinoma (2023) (0)
559 ANALYSIS OF A PROMOTER POLYMORPHISM OF THE GLUT1 GENE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2010) (0)
Glucose transporter isoform 1 (GLUT1) expression determines tumorigenicity of melanoma cells and their potential to form hepatic metastasis (2014) (0)
Genet ics Correlation between Iron Status and Genetic Hemochromatosis ( Codon C 282 Y ) in a Large German Population (2003) (0)
Systemic chemical sympathectomy does not alter the long-term course of disease in a murine model of non-alcoholic steatohepatitis (2011) (0)
The hop chalcone xanthohumol beneficially affects hepatocellular lipid metabolism (2011) (0)
928 Deficiency of Intestinal Mucin-2 Protects From Alcoholic Liver Disease in Mice (2012) (0)
Activated human hepatic stellate cells express CD14 and toll like receptors 2 and 4 (TLR-2, TLR-4) (2000) (0)
Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatic Fibrosis (2020) (0)
P-13ISO-ALPHA-ACIDS FROM HOPS ATTENUATE ACUTE ALCOHOL-INDUCED LIVER STEATOSIS IN MICE (2015) (0)
Gender specific differences in Western-type diet induced steatohepatitis in mice (2018) (0)
Antifibrotic effects of adiponectin include induction of BMP-activated and membrane bound inhibitor (Bambi) in liver cells which antagonizes TGF-beta activity (2011) (0)
Expression of growth differentiation factor 5 in liver fibrosis and cancer (2023) (0)
Subject Index Vol. 19, 2001 (2002) (0)
Role of methylthioadenosine phosphorylase (MTAP) in hepatic stellate cell activation (2013) (0)
Xanthohumol improves glucose tolerance and inhibits hepatic steatosis, inflammation and fibrogenesis in a murine model of non-alcoholic steatohepatitis (2012) (0)
Activated hepatic stellate cells promote growth and inhibit apoptosis of hepatocellular carcinoma (2006) (0)
Irinotecan induced disturbance of bile acid homeostasis promotes hepatocellular injury and inflammation (2018) (0)
Four-and-a-half LIM-domain protein affects diet induced (hepatic) steatosis and lipid droplet formation (2018) (0)
A steatotic environment promotes the progression of hepatocellular carcinoma via direct and indirect mechanisms (2015) (0)
Causal modeling of stroma-cancer cell communication (2015) (0)
Alcohol dehydrogenase 3∗1 genotype is associated with hepatocellular carcinoma in alcohol-induced liver cirrhosis (2003) (0)
Enhanced Expression of Fibroblast Growth Factor 9 in Hepatic Fibrosis (2022) (0)
Processing of MIA2 is important for its tumor suppressor function in hepatocellular carcinoma (2015) (0)
364 DOWNREGULATION OF METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) EXPRESSION IN CHRONIC LIVER DISEASE PROMOTES HEPATIC INFLAMMATION AND FIBROSIS (2012) (0)
NFκB mediates LPS-induced expression of IL-6 and ICAM-1 in activated hepatic stellate cells, a process blocked by proteasome inhibitors (1998) (0)
Pregnancy-associated plasma protein-A is increased in hepatic fibrosis and affects proliferation and activation of hepatic stellate cells (2018) (0)
A novel microRNA-MAPK14-ATF2 axis contributes to hepatocellular carcinoma progression and sorafenib-resistance (2023) (0)
Expression and function of neuroblastoma RAS viral oncogene homolog (NRAS) in hepatocellular carcinoma (2019) (0)
A novel in vitro model for joint effects of alcohol and free fatty acids on hepatocellular steatosis and inflammation (2013) (0)
Four-and-a-half LIM-domain protein (FHL2) affects diet induced obesity, diabetes and hepatic steatosis and inflammation (2022) (0)
Adenoviral gene delivery of interleukin-10 inhibits kupffer cells avtivation in vitro (2007) (0)
CYP2E1 is a central mediator for the synergistic effects of alcohol and free fatty acids on hepatocellular steatosis and inflammation (2014) (0)
Impaired intestinal defensin production leads to bacterial translocation and subsequently aggravates hepatic inflammation and fibrogenesis in an experimental NASH model – a new second hit (2010) (0)
Rapamycin aggravates experimental non alcoholic steatohepatitis in mice (2011) (0)
79 The role of genetic polymorphisms of matrixmetallo-proteinase-3 and transforming growth factor beta-1 in alcoholic liver cirrhosis (2004) (0)
Atrophin 2 expression in chronic liver disease functionally affects activated hepatic stellate cells (2012) (0)
Expression and function of glucose transporter 1 (GLUT1) expression in activated hepatic stellate cells (2014) (0)
313 Expression pattern of the novel melanoma inhibitory activity gene 2 (MIA2) in healthy and diseased human liver (2004) (0)
Downregulation of methylthioadenosine phosphorylase (MTAP) expression in chronic liver disease promotes hepatic inflammation and fibrosis (2012) (0)
Serum markers for hepatic fibrosis in chronic hepatitis C (2000) (0)
[Liver histology in hepatitis C: correlation with different biochemical and virological parameters]. (2000) (0)
928 DEFICIENCY OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AGGRAVATES INFLAMMATION AND FIBROSIS IN EXPERIMENTAL NON ALCOHOLIC STEATOHEPATITIS BUT PROTECTS AGAINST BILE DUCT LIGATION INDUCED FIBROSIS IN VIVO (2010) (0)
700 LIVER REGENERATION AUGMENTING PROTEIN ALR REDUCES LIPOTOXICITY AND PROFIBROGENIC GENE EXPRESSION IN VITRO (2009) (0)
Contents Vol. 19, 2001 (2002) (0)
Expression and Function of Fibroblast Growth Factor 9 in hepatocellular carcinoma (2020) (0)
Secretion and Glycolysis of Human Monocytes Lactic Acid and Acidification Inhibit TNF (2011) (0)
Hepatic steatosis potentiates irinotecan-induced hepatocellular injury via dysregulation of irinotecan-metabolizing enzymes (2018) (0)
983 LIPID ACCUMULATION INDUCES PRODUCTION OF PRO-INFLAMMATORY INTERLEUKIN-8 IN HUMAN HEPATOCYTES VIA ACTIVATION OF JNK - A POTENTIAL STEP IN THE PROGRESSION TO NASH (2008) (0)
Aldosterone stimulates the non-genomic signaling pathway of the mineralocorticoid receptor in hepatic stellate cells (2015) (0)
Increased expression of Fat1 in hepatocellular carcinoma promotes tumorigenicity (2010) (0)
Liver and Immunology: Falk Workshop, Regensburg, January 2011 (2011) (0)
P1115 : ERK And P38 activation are central mediators of irinotecan-induced steatohepatitis (2015) (0)
Author's response to reviews Title: ENMD-1198, a novel tubulin-binding agent reduces HIF-1 and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo Authors: (2008) (0)
Keratinocyte growth factor inhibits hepatic inflammation and fibrosis in murine models of hepatic injury (2014) (0)
Deficiency of phosphatidylinositol 3-kinase (PI3K) aggravates inflammation and fibrosis in experimental NASH in vivo (2010) (0)
Functional effects of monocarboxylate transporter 1 expression in activated hepatic stellate cells (2015) (0)
Effects of Heme Oxygenase–1 Overexpression on Liver Injury after Bile Duct Ligation in Rats (2005) (0)
Glucose transporter isoform 1 (GLUT1) expression in melanoma enhances formation and growth of hepatic metastases (2013) (0)
723 Expression of HDAC1, 2, 3 and 7 as a prognostic markers in hepatocellular carcinoma (2010) (0)
Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation (2018) (0)
Increased expression of pregnancy-associated plasma protein-A in activated hepatic stellate cells is a potential therapeutic target and serum marker of hepatic fibrosis (2018) (0)
Expression and function of methylthioadenosine phosphorylase (MTAP) in chronic liver disease (2011) (0)
Protective effects of Iso-Alpha Acids (IAA) on hepatic steatosis, inflammation and fibrosis (2014) (0)
Repopulation of gene altered Kupffer cells to rat liver Studies in an ischemia-reperfusion model (2002) (0)
Pregnancy-associated plasma protein-A as potential novel target and serum marker for hepatic fibrosis (2019) (0)
Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma (2020) (0)
Does it matter not only how much but also when we eat to induce fatty liver? (2011) (0)
510 THE FORKHEAD BOX A2 TRANSCRIPTION FACTOR REGULATES THE HEPATOTROPHIC PROTEIN ALR (AUGMENTER OF LIVER REGENERATION) (2008) (0)
Lipid Accumulation in Host Cells Promotes SARS-CoV-2 Replication (2023) (0)
Loss of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity (2013) (0)
567 A functional polymorphism in the glutathione-S-transferase P1 gene determines the progression to cirrhosis in patients with hereditary hemochromatosis (2004) (0)
Enhanced expression of bone morphogenetic protein endothelial cell-precursor derived regulator in liver fibrosis (2022) (0)
Expression and function of Epithelial Splicing Regulatory Protein 1 in hepatocellular carcinoma (2020) (0)
' s response to reviews Title : ENMD-1198 , a novel tubulin-binding agent reduces HIF-1 and STAT 3 activity in human hepatocellular carcinoma ( HCC ) cells , and inhibits growth and vascularization in vivo (2008) (0)
Association of polymorphous light eruption with NOD‐2 and TLR‐5 gene polymorphisms (2022) (0)
Expression of Intercellular Adhesion Molecule 1 by Activated Hepatic Stellate Cells (1998) (0)
Xanthohumol, a prenylated chalcone derived from hops (Humulus lupulus), inhibits hepatic metastasis (2016) (0)
REGENSBURG HEPATIC STEATOSIS CAUSES INDUCTION OF THE CHEMOKINE RANTES IN THE ABSENCE OF SIGNIFICANT HEPATIC INFLAMMATION Inaugural – (2012) (0)
KLINIK UND POLIKLINIK FÜR INNERE MEDIZIN I PROF. DR. MARTINA MÜLLER-SCHILLING DER MEDIZINISCHEN FAKULTÄT DER UNIVERSITÄT REGENSBURG ANALYSIS OF SYSTEMIC MONOCYTE CHEMOATTRACTANT PROTEIN-1 LEVELS IN PATIENTS WITH AND WITHOUT SONOGRAPHIC EVIDENT HEPATIC STEATOSIS Inaugural – Dissertation zur Erlan (2013) (0)
Chapter 5 – Capillary Electrophoresis (2010) (0)
Age and gender dependent differences in BMP6 mediated hepcidin expression and iron homeostasis (2011) (0)
109 The chemokine CXCL9 (MIG) is associated with liver fibrogenesis in mice and humans (2006) (0)
Expression of fibroblast growth factor receptors in hepatocellular carcinoma (2022) (0)
Deficiency of phosphatidylinositol 3-kinase (PI3K) aggravates hepatic inflammation and fibrosis in experimental NASH but protects against bile duct ligation induced liver fibrosis (2011) (0)
1232 XANTHOHUMOL IMPROVES GLUCOSE TOLERANCE AND INHIBITS HEPATIC STEATOSIS, INFLAMMATION AND FIBROGENESIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (2012) (0)
Adiponectin elevates activin A and reduces follistatin via the adiponectin receptor 2 in primary human hepatocytes (2009) (0)
Fibroblast growth factor 7 inhibits hepatic steatosis, inflammation and fibrosis in murine models of on non-alcoholic steatohepatitis (2015) (0)
Down-regulation of Alk2 and hemojuvelin protects from disturbance of iron homeostasis by increased BMP expression in hepatocellular carcinoma (2010) (0)
[Clinical and genetic aspects of hereditary hemochromatosis]. (2001) (0)
Four-and-a-half LIM-domain protein (FHL2) affects diet induced (hepatic) steatosis and and lipid droplet formation (2018) (0)
Synergistic effects of alcohol and high-fat diet on hepatic injury – a new model to study alcoholic steatohepatitis (2010) (0)
342 Methylthioadenosin phosphorylase (MTAP) expression is frequently lost in hepatocellular carcinoma (2004) (0)
Functional effects of methylthioadenosine phosphorylase (MTAP) expression in chronic liver disease (2013) (0)
Expression and function of the atypical cadherin Fat1 in liver fibrosis (2011) (0)
Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatocellular Carcinoma (2020) (0)
The hop constituent xanthohumol exhibits hepatoprotective effects against acute alcohol-induced liver injury (2018) (0)
The common functional C(−159)T polymorphism of the LPS receptor CD14 does not influence the disease outcome in patients with chronic hepatitis C infection (2002) (0)
Novel feedback inhibition of the let-7 microRNA regulator and stem cell marker Lin 28 homolog A by tumorsuppressor miR-622 in hepatocellular carcinoma (2018) (0)
Subject Index Vol. 34, Suppl. 1, 2016 (2016) (0)
Bile salts induce interleukin 8 expression in human intestinal epithelial cells (2001) (0)
A novel Krueppel-like factor 12/Interleukin-6 signal transducer – microRNA-188-5 p interaction reveals therapeutic targets for hepatocellular carcinoma (2018) (0)
IL–6 and IL–1 enhance hepatic expression of ALR (Augmenter of Liver Regeneration) (2008) (0)
Gender differences in Western-type diet-induced alterations of lipid metabolisms in the liver and adipose tissue of mice (2021) (0)
Doxorubicin induces tumorigenicity and chemotherapy resistance of residual hepatocellular carcinoma cells in vitro (2014) (0)
A hepatocyte nuclear factor-3 site in ALR promoter is important for interleukin 6-induced expression (2009) (0)
Meeting Report: Intestinal BMP6, a Master Gene for the Regulation of Iron Homeostasis (2011) (0)
THE 5A/5A GENETIC POLYMORPHISMS OF MATRIXMETALLO-PROTEINASE-3 IS ASSOCIATED WITH THE PROGRESSION TO CIRRHOSIS IN ALCOHOLIC LIVER DISEASE. (2004) (0)
Aging promotes hepatocellular steatosis, inflammation and fibrosis in non-alcoholic steatohepatitis in mice (2012) (0)
Original Article Increased expression of Zinc finger protein 267 in non-alcoholic fatty liver disease (2011) (0)
Alcohol and a high-fat diet synergistically induce hepatic inflammation and fibrosis via TLR4 (2011) (0)
S06-3EFFECTS OF THE HOP FLAVONOID XANTHOHUMOL ON ALCOHOL INDUCED LIVER INJURY (2017) (0)
Lack of expression of methylthioadenosin phosphorylase (MTAP) in normal human colonic epithelial cells (2004) (0)
Expression of the atypical cadherin Fat1 in hepatic fibrosis (2012) (0)
The role of mechanistic target of rapamycin complex 2-component RICTOR in hepatocellular carcinoma progression and sorafenib-resistance (2018) (0)
BMP6 protects against hepatic fibrosis in experimental NASH models (2011) (0)
Role of Fibroblast Growth Factors and Their Receptors in Liver Fibrosis and Repair (2015) (0)
Contribution of common variants in the complement factor H gene to fibrogenesis in chronic hepatitis C virus (HCV) infection (2007) (0)
TNF receptor superfamily member 10 d is a novel diagnostic and therapeutic target in hepatocellular carcinoma progression and sorafenib-resistance (2018) (0)
Role of enhanced bone morphogenetic protein-endothelial cell-precursor derived regulator in hepatocellular carcinoma (2022) (0)
Aging promotes susceptibility to non-alcoholic steatohepatitis in mice (2011) (0)
Identification of Fibroblast Growth Factor Receptor 2IIIb (FGFR2IIIb) as tumor suppressor in hepatocellular carcinoma (2008) (0)
Human Intestinal Epithelial Cells B Super-Repressor in k of a Nuclear Factor Production by Adenovirus-Mediated Expression Inhibition of Proinflammatory Molecule (1997) (0)
The fraktalkine receptor CX3CR1 is associated with progression of liver fibrosis in patients with chronic hepatitis C (2006) (0)
Aging promotes progression of non-alcoholic fatty liver disease in mice (2013) (0)
Augmenter of Liver Regeneration Modulates Hepatic Metabolism by Reduction of Cytochrom P450 Activity in Human Hepatocytes in Vitro (2005) (0)
[130] ADENOVIRAL GENE DELIVERY OF INTERLEUKIN-10 REDUCES HEPATIC ISCHEMIA-REPERFUSION INJURY IN RATS THRU INHIBITION OF KUPFFER CELL ACTIVATION (2007) (0)
Deficiency of PI3K enhances inflammation and fibrosis in experimental non alcoholic steatohepatitis but attenuates bile duct ligation induced fibrosis in vivo (2010) (0)
Neprilysin-neuropeptide Y axis as target for treatment of liver fibrosis and portal hypertension (2020) (0)
Antifibrotic properties of transarterial VSV oncolytic therapy for hepatocellular carcinoma in rats with TAA-induced liver fibrosis (2011) (0)
In vitro and in vivo models for chemotherapy-associated steatohepatitis reveal an effect of irinotecan on fatty acid binding protein expression (2012) (0)
582 EXPRESSION OF HDAC ISOENZYMES AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA (2010) (0)
Original Article Expression of fatty acid synthase in nonalcoholic fatty liver disease (2010) (0)
The kinase inhibitor DMAT reduces experimental HCC growth in mice (2011) (0)
Attenuation of lipotoxicity by liver regeneration protein ALR (2010) (0)
Adenoviral gene delivery of interleukin-10 reduces hepatic ischemia-reperfusion injury in rats (2007) (0)
Rare diseases of the digestive system (2016) (0)
Corrigendum to “Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in-vitro” [Exp. Mol. Pathol. 91-3 (2011) 733–739] (2012) (0)
Gender-specific differences in a murine model of non-alcoholic steatohepatitis (2013) (0)
403 EXPRESSION AND FUNCTION OF THE ATYPICAL CADHERIN FAT1 IN HEPATIC FIBROSIS (2012) (0)
Role of fibroblast growth factor 9 in the regulation of hepatic bile acid homeostasis (2023) (0)
Hepatic steatosis potentiates irinotecan-induced hepatocellular steatohepatitis via dysregulation of irinotecan-metabolizing enzymes (2019) (0)
Regulation and function of Fibroblast Growth Factor Receptor 2IIIb (FGFR2IIIb) in hepatocancerogenesis (2007) (0)
Analysis of a functional promoter polymorphism of the MCP–1 gene in patients with spontaneous bacterial peritonitis (2008) (0)
Rapamycin decreases proinflammatory and profibrogenic gene expression in experimental NASH (2009) (0)
Hepatic steatosis promotes growth and invasiveness of hepatocellular carcinoma cells in vitro and in vivo (2015) (0)
Combined effects of polo-like kinase 1 and harvey rat sarcoma in hepatocellular carcinoma reveal novel therapeutic strategies (2018) (0)
The long non-coding RNAs lncRNA-ADM-2 and lncRNA-NBPF3-9 outline potential novel targets for hepatocellular carcinoma (2018) (0)
1260 AGING PROMOTES HEPATOCELLULAR STEATOSIS, INFLAMMATION AND FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS IN MICE (2012) (0)
Regulation and Function of the atypical cadherin FAT1 in hepatocellular carcinoma (2013) (0)
P0278 : Hepatic steatosis and high circulating free fatty acid levels promote growth and invasiveness of hepatocellular carcinoma (2015) (0)
Novel in vitro models of alcohol-mediated hepatic injury (2012) (0)
Analysis of the expression and function of KIAA1199 in hepatocellular carcinoma (2020) (0)
Chain length and saturation status of fatty acids significantly affect cellular injury and lipid metabolism of primary human hepatocytes (2019) (0)
Hepatic stellate cells—the pericytes in the liver (2013) (0)
HGF mediated downregulation of the novel gene MIA2 promotes progression of hepatocellular carcinoma (2007) (0)
Cytokines induce NF- (cid:107) B in activated but not in quiescent rat hepatic stellate cells (1998) (0)
Muscle RAS oncogene homolog is a novel therapeutic target gene contributing to hepatocellular carcinoma progression and sorafenib-resistance (2018) (0)
Establishment of an in vitro model in which HBV promotes hepatocellular steatosis and lipotoxicity (2012) (0)
Xanthohumol inhibits the development of non-alcoholic steatohepatitis by systemic as well as direct effects on hepatocellular lipid uptake (2013) (0)
928 ELEVATED ADIPONECTIN SERUM LEVELS IN PATIENTS WITH CHRONIC ALCOHOL ABUSE RAPIDLY DECREASE DURING ALCOHOL WITHDRAWAL (2008) (0)
In vitro and in vivo models for irinotecan induced steatohepatitis (2013) (0)
98 The novel gene MIA2 promotes progression of hepatocellular carcinoma (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Claus Hellerbrand?

Claus Hellerbrand is affiliated with the following schools:

University of Erlangen–Nuremberg
University of Regensburg
University of North Carolina at Chapel Hill

Claus Hellerbrand's Academic­Influence.com Rankings

Why Is Claus Hellerbrand Influential?

Claus Hellerbrand's Published Works

Published Works

What Schools Are Affiliated With Claus Hellerbrand?

Claus Hellerbrand's AcademicInfluence.com Rankings